ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 108 filers reported holding ENZO BIOCHEM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $84,000 | -16.8% | 23,399 | -21.7% | 0.00% | -33.3% |
Q2 2019 | $101,000 | +21.7% | 29,899 | +47.4% | 0.01% | +50.0% |
Q3 2018 | $83,000 | -27.8% | 20,282 | -3.5% | 0.00% | -20.0% |
Q1 2018 | $115,000 | -0.9% | 21,007 | +98.7% | 0.01% | -16.7% |
Q2 2017 | $116,000 | +14.9% | 10,573 | -38.0% | 0.01% | +20.0% |
Q2 2016 | $101,000 | +44.3% | 17,061 | +25.2% | 0.01% | +66.7% |
Q3 2014 | $70,000 | +11.1% | 13,625 | +12.4% | 0.00% | 0.0% |
Q2 2014 | $63,000 | – | 12,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |